Nov 11 (Reuters)-
Medrx.Co., Ltd.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Sep 30, 2022 Sep 30, 2021 Dec 31, 2022
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 9 mln 8 mln 359 mln
(+14.0 pct) (-44.9 pct)
Operating loss 621 mln loss 675 mln loss 881 mln
Recurring loss 636 mln loss 680 mln loss 900 mln
Net loss 635 mln loss 677 mln loss 899 mln
EPS loss 25.82 yen loss 32.93 yen loss 36.06 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Medrx.Co., Ltd..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4586.T